(Q64098474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

8 September 2020

Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

cancer-associated fibroblast

29 April 2020

main subject

tumor microenvironment

1 reference

8 September 2020

1 reference

8 September 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Serena Mazzucchelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Renzo Vanna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Carlo Morasso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Fabio Corsi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Arianna Bonizzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Luca Sorrentino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Raffaele Allevi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Marta Truffi

1

0 references

Serena Mazzucchelli

2

0 references

Renzo Vanna

6

0 references

Carlo Morasso

7

0 references

Fabio Corsi

8

0 references

language of work or name

English

0 references

publication date

13 March 2019

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

8 September 2020

January 2019

0 references

full work available at URL

https://www.mdpi.com/1422-0067/20/6/1263

0 references

published in

International Journal of Molecular Sciences

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

8 September 2020

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

29 April 2020

page(s)

1263

0 references

copyright license

1 reference

8 September 2020

0 references

The common acute lymphoblastic leukemia antigen (CD10)--emancipation from a functional enigma.

1 reference

12 December 2020

The distribution of secondary growths in cancer of the breast. 1889

1 reference

12 December 2020

An overview of epithelio-mesenchymal transformation

1 reference

12 December 2020

Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis

1 reference

12 December 2020

Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors

1 reference

12 December 2020

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

1 reference

12 December 2020

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

1 reference

12 December 2020

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

1 reference

12 December 2020

PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

1 reference

12 December 2020

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

1 reference

12 December 2020

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

12 December 2020

Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy

1 reference

12 December 2020

An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2

1 reference

12 December 2020

Fibroblasts in cancer

1 reference

12 December 2020

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

1 reference

12 December 2020

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

1 reference

12 December 2020

Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.

1 reference

12 December 2020

Collagen density promotes mammary tumor initiation and progression

1 reference

12 December 2020

Regulation of in situ to invasive breast carcinoma transition

1 reference

12 December 2020

Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.

1 reference

12 December 2020

CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells

1 reference

12 December 2020

Pten in stromal fibroblasts suppresses mammary epithelial tumours

1 reference

12 December 2020

The polarization of immune cells in the tumour environment by TGFbeta

1 reference

12 December 2020

Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.

1 reference

12 December 2020

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

1 reference

12 December 2020

Photodynamic therapy of cancer: an update

1 reference

12 December 2020

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

1 reference

12 December 2020

The extracellular matrix: a dynamic niche in cancer progression

1 reference

12 December 2020

CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells

1 reference

12 December 2020

Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm

1 reference

12 December 2020

Stromal cells in tumor microenvironment and breast cancer

1 reference

12 December 2020

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

1 reference

12 December 2020

The tumor microenvironment at a glance.

1 reference

12 December 2020

Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.

1 reference

12 December 2020

Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia.

1 reference

12 December 2020

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

1 reference

12 December 2020

Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer

1 reference

12 December 2020

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

1 reference

12 December 2020

Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation

1 reference

12 December 2020

Molecular mechanisms of epithelial-mesenchymal transition

1 reference

12 December 2020

The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy

1 reference

12 December 2020

Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma

1 reference

12 December 2020

Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models

1 reference

12 December 2020

Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery

1 reference

12 December 2020

Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression

1 reference

12 December 2020

T cell exclusion, immune privilege, and the tumor microenvironment

1 reference

12 December 2020

The cancer-associated fibroblasts and drug resistance.

1 reference

12 December 2020

Nanomedicines Targeting the Tumor Microenvironment

1 reference

12 December 2020

Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment

1 reference

12 December 2020

3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation

1 reference

12 December 2020

Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation.

1 reference

12 December 2020

Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin

1 reference

12 December 2020

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

1 reference

12 December 2020

Preclinical mouse cancer models: a maze of opportunities and challenges

1 reference

12 December 2020

Immunological hallmarks of stromal cells in the tumour microenvironment

1 reference

12 December 2020

A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts.

1 reference

12 December 2020

Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

1 reference

12 December 2020

Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go

1 reference

12 December 2020

Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer

1 reference

12 December 2020

Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy.

1 reference

12 December 2020

Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.

1 reference

12 December 2020

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling

1 reference

12 December 2020

The biology and function of fibroblasts in cancer

1 reference

12 December 2020

Tumor microenvironment-mediated chemoresistance in breast cancer.

1 reference

12 December 2020

Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens

1 reference

12 December 2020

Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors

1 reference

12 December 2020

Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.

1 reference

12 December 2020

Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis.

1 reference

12 December 2020

Progress in nonviral gene therapy for breast cancer and what comes next?

1 reference

12 December 2020

Transformable Nanomaterials as an Artificial Extracellular Matrix for Inhibiting Tumor Invasion and Metastasis.

1 reference

12 December 2020

Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.

1 reference

12 December 2020

Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration.

1 reference

12 December 2020

Nano-targeting of mucosal addressin cell adhesion molecule-1 identifies bowel inflammation foci in murine model.

1 reference

12 December 2020

Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.

1 reference

12 December 2020

Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.

1 reference

12 December 2020

Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer

1 reference

12 December 2020

Nanomedicine applications in the treatment of breast cancer: current state of the art.

1 reference

12 December 2020

Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.

1 reference

12 December 2020

Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.

1 reference

12 December 2020

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

1 reference

12 December 2020

Targeting immune checkpoints in breast cancer: an update of early results.

1 reference

12 December 2020

GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment

1 reference

12 December 2020

Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.

1 reference

12 December 2020

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.

1 reference

12 December 2020

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

1 reference

12 December 2020

Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells.

1 reference

12 December 2020

A peek into cancer-associated fibroblasts: origins, functions and translational impact.

1 reference

12 December 2020

Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.

1 reference

12 December 2020

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates

1 reference

12 December 2020

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.

1 reference

12 December 2020

Fibroblasts in the Tumor Microenvironment: Shield or Spear?

1 reference

12 December 2020

Photosensitizer-Encapsulated Ferritins Mediate Photodynamic Therapy against Cancer-Associated Fibroblasts and Improve Tumor Accumulation of Nanoparticles

1 reference

12 December 2020

Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment

1 reference

12 December 2020

Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers

1 reference

12 December 2020

Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo

1 reference

12 December 2020

Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer

1 reference

12 December 2020

Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer

1 reference

12 December 2020

Curcumin in Combination with Anti-Cancer Drugs: A Nanomedicine Review

1 reference

12 December 2020

Turning foes to friends: targeting cancer-associated fibroblasts

1 reference

12 December 2020

Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway

1 reference

12 December 2020

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

1 reference

12 December 2020

Recent Development of pH-Responsive Polymers for Cancer Nanomedicine

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS20061263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30871158%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference